SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
422<i>why aren't more antibodies described, from academic collaborators, nigel bates-10/2/2002
421Monoclonal antibody drug sales soaring -report Tuesday October 1, 6:59 pm ET LOIcebrg-10/2/2002
420Dow Obtains Patents for Production of Glycoproteins In Transgenic Plant Systems scaram(o)uche-10/1/2002
419Thanks [eom]Miljenko Zuanic-10/1/2002
418>> Rick, please can you be bit more specific, in plain language? << scaram(o)uche-9/30/2002
417"If you're trying to produce anything anti-human, there are very simpleMiljenko Zuanic-9/30/2002
416Again..... why aren't more antibodies described, from academic collaboratscaram(o)uche-9/30/2002
415The CAT / Chugai deal is interesting given that Roche is acquiring a majority stnigel bates-9/30/2002
414Cambridge Antibody Technology Partners With Chugai to Develop Novel Human Monoclnigel bates-9/30/2002
413Genmab shares more than 50% down after the company suspended the development of Jibacoa-9/25/2002
412<b>Progenics and Cytogen Report Positive Preclinical Results for ExperimenIcebrg-9/23/2002
411BAGSVAERD, Denmark, Sept. 20 /PRNewswire/ -- Novozymes and US-based Neugenesis enigel bates-9/20/2002
410Untill Iressa AC review is completed expect more volatility for OSIP and ABGX. Miljenko Zuanic-9/18/2002
409WESTBOROUGH, Mass., Sept. 18 /PRNewswire/ -- Now in it's 13th year, IBC'nigel bates-9/18/2002
408Abgenix cap under $600m... <pre>CONSOLIDATED BALANCE SHEET DATA (in thounigel bates-9/18/2002
407SAN DIEGO--(BUSINESS WIRE)--Sept. 16, 2002-- Epicyte Pharmaceutical, Inc., a Sannigel bates-9/16/2002
406BERKELEY, Calif. and SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- XOMA Ltd. (Nanigel bates-9/10/2002
405OXFORD, U.K.--(BUSINESS WIRE)--Sept. 9, 2002--The Board of British Biotech plc hnigel bates-9/9/2002
404COPENHAGEN, Denmark, Sept. 4 /PRNewswire-FirstCall/ -- Genmab A/S (CSE: GEN and nigel bates-9/4/2002
403aka GA733, CO17-1A, KSA and KS1-4, this antigen has been described AS A CARCINOMscaram(o)uche-9/2/2002
402<b>Novuspharma To Co-Develop Micromet's Human Antibody MT201 For The TIcebrg-9/2/2002
401A nasty from the MEDX results - <i>...In addition, during the second quartnigel bates-8/14/2002
400SIOUX FALLS, S.D.--(BW HealthWire)--Aug. 12, 2002 Scientists today reported thenigel bates-8/12/2002
399Genmab/Semaia: Firms To Share Costs, Revenues COPENHAGEN -(Dow Jones)- Danish bIcebrg-7/31/2002
398Genmab to delist from Frankfurt By David Firn in London Published: July 28 2002 Icebrg-7/29/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News